Low frequency of PIK3CA gene mutations in hepatocellular carcinoma in Chinese population

Pathology and Oncology Research

Volumn 18, Issue 1, 2012, Pages 57-60

  Li, Xun ^a,b   Zhang, Quanbao ^a   He, Wenting ^a,b   Meng, Wenbo ^a   Yan, Jun ^a   Zhang, Lei ^a   Zhu, Xiaoliang ^a   Liu, Tao ^a,b   Li, Yumin ^a,b   Bai, Zhongtian ^a  

^a LANZHOU UNIVERSITY   (China)

^b Key Laboratory of Digestive System   (China)

Author keywords

Gene mutation; Hepatitis B virus; Hepatocellular carcinoma; PIK3CA

Indexed keywords

ALPHA FETOPROTEIN; GENOMIC DNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER STAGING; CHINESE; DISEASE ASSOCIATION; DNA SEQUENCE; EXON; FEMALE; GENE; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; PIK3CA GENE; POINT MUTATION; POLYMERASE CHAIN REACTION; POPULATION GENETICS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHINA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMERASE CHAIN REACTION;

EID: 84855291181     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9416-5     Document Type: Article

References (28)

1. Parkin DM, Whelan SL, Ferlay J, et al (2005) Cancer incidence in five continents, Vols. I to VIII (IARC Cancer Base). International Agency for Research on Cancer
2. JY Zhang M Dai X Wang, et al. 1998 A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan China Int J Epidemiol 27 574 578 10.1093/ije/27.4.574 1:STN:280: DyaK1cvivFSktA%3D%3D (Pubitemid 28431497)
3. M Osaki M Oshimura H Ito 2004 PI3K-Akt pathway: its functions and altertions in human cancer Apoptosis 9 667 676 15505410 10.1023/B:APPT. 0000045801.15585.dd 1:CAS:528:DC%2BD2cXovVKqu70%3D (Pubitemid 40941196)
4. Y Samuels Z Wang A Bardelli, et al. 2004 High frequency of mutations of the PIK3CA gene in human cancers Science 23 554 10.1126/science.1096502 (Pubitemid 38541907)
5. H Yamamoto H Shigematsu M Nomura, et al. 2008 PIK3CA mutations and copy number gains in human lung cancers Cancer Res 68 6913 6921 18757405 10.1158/0008-5472.CAN-07-5084 1:CAS:528:DC%2BD1cXhtVCrs7%2FK
6. K Okudela M Suzuki S Kageyama, et al. 2007 PIK3CA mutation and amplification in human lung cancer Pathol Int 57 664 671 17803655 10.1111/j.1440-1827.2007.02155.x 1:CAS:528:DC%2BD2sXhtF2rtr7N (Pubitemid 47353042)
7. J Souglakos J Philips R Wang, et al. 2009 Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer Br J Cancer 101 465 472 19603024 10.1038/sj.bjc.6605164 1:CAS:528:DC%2BD1MXpsVKmsr4%3D
8. A Sartore-Bianchi M Martini F Molinari, et al. 2009 PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies Cancer Res 69 1851 1857 19223544 10.1158/0008-5472.CAN-08- 2466 1:CAS:528:DC%2BD1MXisFSrt7Y%3D
9. WA Phillips SE Russell ML Ciavarell, et al. 2006 Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus Int J Cancer 118 2644 2646 16380997 10.1002/ijc.21706 1:CAS:528:DC%2BD28XktlGhs7o%3D
10. R Mori H Ishiguro M Kimura, et al. 2008 PIK3CA mutation status in Japanese esophageal squamous cell carcinoma J Surg Res 145 320 326 18262558 10.1016/j.jss.2007.03.044 1:CAS:528:DC%2BD1cXjtVeqtLw%3D
11. K Kalinsky LM Jacks A Heguy, et al. 2009 PIK3CA mutation associates with improved outcome in breast cancer Clin Cancer Res 15 5049 5059 19671852 10.1158/1078-0432.CCR-09-0632 1:CAS:528:DC%2BD1MXpvFeis78%3D
12. K Stemke-Hale AM Gonzalez-Angulo A Lluch, et al. 2008 An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer Cancer Res 68 6084 6091 18676830 10.1158/0008-5472.CAN-07-6854 1:CAS:528:DC%2BD1cXpt1SqtLs%3D
13. S Velho C Oliveira A Ferreira, et al. 2005 The prevalence of PIK3CA mutations in gastric and colon cancer Eur J Cancer 41 1649 1654 15994075 10.1016/j.ejca.2005.04.022 1:CAS:528:DC%2BD2MXmsVCmu7s%3D (Pubitemid 40981849)
14. L Vivian W Chi C Tsun, et al. 2005 Mutations of PIK3CA in gastric adenocarcinoma BMC Cancer 5 29 34 10.1186/1471-2407-5-29 (Pubitemid 41461099)
15. KT Kuo TL Mao S Jones, et al. 2009 Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma Am J Pathol 174 1597 1601 19349352 10.2353/ajpath.2009.081000 1:CAS:528:DC%2BD1MXlvVWnuro%3D
16. A Jehad B Prashant AH Wael, et al. 2009 PIK3CA alterations in Middle Eastern ovarian cancers Mol Cancer 8 51 53 10.1186/1476-4598-8-51
17. JW Lee YH Soung SY Kim, et al. 2005 PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas Oncogene 24 1477 1480 15608678 10.1038/sj.onc.1208304 1:CAS:528:DC%2BD2MXhtlOku78%3D (Pubitemid 40343128)
18. S Boyault DS Rickman A Reynies, et al. 2007 Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets Hepatology 45 42 52 17187432 10.1002/hep.21467 1:CAS:528:DC%2BD2sXht1arsb4%3D (Pubitemid 46144363)
19. M Riener M Bawohl PA Clavien, et al. 2008 Rare PIK3CA hotspot mutations in carcinomas of the biliary tract Genes Chromosome Canc 47 363 367 10.1002/gcc.20540 1:CAS:528:DC%2BD1cXkt1amtr4%3D (Pubitemid 351451790)
20. Y Tanaka F Kanai M Tada, et al. 2006 Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients Oncogene 25 2950 2952 16331247 10.1038/sj.onc.1209311 1:CAS:528:DC%2BD28XksVGnsb4%3D (Pubitemid 43739246)
21. JM Llovet C Bru J Bruix 1999 Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 329 338 10518312 10.1055/s-2007-1007122 1:STN:280:DyaK1Mvks1Grsg%3D%3D
22. S Kang AG Bader PK Vogt 2005 Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic Proc Natl Acad Sci USA 102 802 807 15647370 10.1073/pnas.0408864102 1:CAS:528:DC%2BD2MXis1Cqsb0%3D (Pubitemid 40282746)
23. T Ikenoue F Kanai Y Hikiba, et al. 2005 Functional analysis of PIK3CA gene mutations in human colorectal cancer Cancer Res 65 4562 4567 15930273 10.1158/0008-5472.CAN-04-4114 1:CAS:528:DC%2BD2MXks1Oht7c%3D (Pubitemid 40740791)
24. Z Liu TM Roberts 2006 Human tumor mutants in the p110 subunit of PI3K Cell Cycle 5 675 677 16627990 10.4161/cc.5.7.2605 1:CAS:528:DC%2BD28XlvVCjtbo%3D
25. M Gymnopoulos MA Elsliger PK Vogt 2007 Rare cancer-specific mutations in PIK3CA show gain of function PNAS 104 5569 5574 17376864 10.1073/pnas.0701005104 1:CAS:528:DC%2BD2sXkt1emtb8%3D (Pubitemid 47175721)
26. KM Mohandas 2004 Hepatitis B associated hepatocellular carcinoma: epidemiology, diagnosis and treatment Hep B Annual 1 140 152
27. Russo MW, Jacobson IM (2002) Hepatocellular cancer: screening, surveillance, and prevention. In: Kelsen DP, Daly JM, Kern SE et al (eds) Gastrointestinal oncology: principles and practices. Lippincott, Williams and Wilkins, Philadelphia, pp 559-568
28. Z Sun L Ming X Zhu, et al. 2002 Prevention and control of hepatitis B in China J Med Virol 67 447 450 12116043 10.1002/jmv.10094 (Pubitemid 34569089)